rs1135071

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PM5PP3

The NM_000518.5(HBB):​c.93G>T​(p.Arg31Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000138 in 1,613,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin Lovd. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R31G) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

HBB
NM_000518.5 missense, splice_region

Scores

7
8
4
Splicing: ADA: 0.9987
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts P:2U:6

Conservation

PhyloP100: 1.84
Variant links:
Genes affected
HBB (HGNC:4827): (hemoglobin subunit beta) The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM1
In a site (Microbial infection) Cleavage; by N.americanus apr-2 (size 1) in uniprot entity HBB_HUMAN there are 8 pathogenic changes around while only 2 benign (80%) in NM_000518.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-5226931-T-C is described in Lovd as [Pathogenic].
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
HBBNM_000518.5 linkuse as main transcriptc.93G>T p.Arg31Ser missense_variant, splice_region_variant 2/3 ENST00000335295.4 NP_000509.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
HBBENST00000335295.4 linkuse as main transcriptc.93G>T p.Arg31Ser missense_variant, splice_region_variant 2/31 NM_000518.5 ENSP00000333994 P1

Frequencies

GnomAD3 genomes
AF:
0.000250
AC:
38
AN:
152152
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00339
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000346
AC:
87
AN:
251316
Hom.:
0
AF XY:
0.000280
AC XY:
38
AN XY:
135804
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00365
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000126
AC:
184
AN:
1461592
Hom.:
0
Cov.:
36
AF XY:
0.000107
AC XY:
78
AN XY:
727138
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00328
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.000116
GnomAD4 genome
AF:
0.000250
AC:
38
AN:
152270
Hom.:
0
Cov.:
32
AF XY:
0.000389
AC XY:
29
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00339
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000407
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.000280
AC:
34

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:2Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMar 02, 2022The Hb Tacoma variant (HBB: c.93G>T; p.Arg31Ser, also known as Arg30Ser when numbered from the mature protein, HbVar ID: 289, rs1135071) is reported in the literature in the heterozygous state in individuals with mild anemia or no symptoms (Deacon-Smith 1978, Idelson 1974, Landin 1993), and in one individual with Hb S who had sickle cell trait (Honig 1980). This variant is also reported in ClinVar (Variation ID: 15368) and is found in the Finnish European population with an allele frequency of 0.36% (90/25120 alleles) in the Genome Aggregation Database. The arginine at codon 31 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.947). This variant is the first nucleotide of the exon, and computational analyses (Alamut v.2.11) predict that this variant may impact splicing by weakening the nearby canonical acceptor splice site. Functional analyses demonstrate a normal oxygen affinity but slight instability (Deacon-Smith 1978, Honig 1980). Due to conflicting information, the clinical significance of the Hb Tacoma variant is uncertain at this time. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Deacon-Smith RA and Lee-Potter JP. An unstable haemoglobin, Hb Tacoma beta30 (B12) arg leads to ser, detected at birth by the demonstration of red cell inclusions. J Clin Pathol. 1978 Sep;31(9):883-7. PMID: 711920. Honig GR et al. Two new sickle cell syndromes: HbS, Hb Camden, and alpha-thalassemia; and HbS in combination with Hb Tacoma. Blood. 1980 Apr;55(4):655-60. PMID: 7357091. Idelson LI et al. New unstable haemoglobin (Hb Moscva, beta24 (B4) Gly leads to Asp) found in the USSR. Nature. 1974 Jun 21;249(459):768-70. PMID: 4525423. Landin B and Jeppsson JO. Rare beta chain hemoglobin variants found in Swedish patients during HBA1c analysis. Hemoglobin. 1993 Aug;17(4):303-18. PMID: 8226093. -
Uncertain significance, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoJun 18, 2023The HBB c.93G>T (p.Arg31Ser) variant (also known as Hb Tacoma) has been reported to have normal oxygen affinity but slightly reduced stability (PMIDs: 31553106 (2020), 7357091 (1980), 5785231 (1969), 5869485 (1965)). Individuals who are heterozygous for this variant have normal presentations (PMID: 5869485 (1965)) or mild anemia (PMIDs: 34233561 (2021), 8226093 (1993), 3937827 (1985)). Co-occurrence of this variant with Hb S presented as clinically healthy (PMID: 7357091 (1980)), but in combination with a beta(+)-thalassemia variant resulted in moderate microcytic anemia (PMID: 10975446 (2000)). Additionally, an individual who was compound heterozygous for Hb Tacoma caused by a different nucleotide change (c.93G>C, p.Arg31Ser) and a HBB pathogenic variant associated with beta(0)-thalassemia is reported to have transfusion-dependent beta thalassemia (PMID: 9140720 (1997)). Analysis of this variant using bioinformatics tools indicates that the effect of this variant's amino acid change on protein structure and function is damaging, and it may also affect proper HBB mRNA splicing. Clinical correlation and genetic counseling are recommended. -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJun 21, 2018This sequence change replaces arginine with serine at codon 31 of the HBB protein (p.Arg31Ser). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and serine. This variant is present in population databases (rs1135071, ExAC 0.3%). This variant has been observed in individuals and families with elevated Hb A2 levels, but most individuals are either clinically unaffected or experience only mild anemia (PMID: 8226093, 4525423, 5869485, 3937827, 7357091). This variant is also known as Arg30Ser and Hb Tacoma in the literature. ClinVar contains an entry for this variant (Variation ID: 15368). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Pathogenic:1Uncertain:1
Pathogenic, flagged submissionliterature onlyOMIMFeb 01, 2002- -
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 30, 2024Variant summary: HBB c.93G>T (p.Arg31Ser) results in a non-conservative amino acid change located in the Globin domain (IPR000971) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. Computational tools predict a significant impact on normal splicing: Three predict the variant weakens a canonical 3' acceptor site. One predicts the variant has no significant impact on splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00035 in 251316 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in HBB causing Beta Thalassemia (0.00035 vs 0.011), allowing no conclusion about variant significance. Hb Tacoma is used to describe the substitution of Arg-to-Ser at codon 31 (legacy codon 30) and can be due to either c.93G>T or c.93G>C. It has been reported in the literature in heterozygous individuals with no clinical or hematological abnormalities apart from mild anemia (Deacon-Smith_1978, Harano_1985, Moore_2021) and in one heterozygous individual who also carried Hb S and had normal hematological findings (Honig_1980). c.93G>T in particular was reported in heterozygous individuals with normal hematological findings in some of them and slight hemolytic anemia in others, while importantly it was also reported in a 12-year-old boy in compound heterozygosity with pathogenic variant c.93-21G>A and no signs of disease (Landin 1993, 2000). The variant was also found in multiuple homozygous individuals without clinical information (Kangastupa_2023). These reports do not provide unequivocal conclusions about association of the variant with Beta Thalassemia. Experimental evidence evaluating an impact on protein function demonstrate the variant to display in vitro instability, including a decreased alkaline Bohr effect and haem-haem interaction but normal oxygen affinity (Deacon-Smith_1978, Hayashi_1974). These data do not allow convincing conclusions about the variant effect The following publications have been ascertained in the context of this evaluation (PMID: 8226093, 6859036, 7357091, 711920, 3937827, 4407364, 10975446, 34233561, 36633442). ClinVar contains an entry for this variant (Variation ID: 15368). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Heinz body anemia Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMFeb 01, 2002- -
beta Thalassemia Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Mar 16, 2021- -
Beta-thalassemia HBB/LCRB Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingMGZ Medical Genetics CenterNov 26, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Pathogenic
0.38
D
BayesDel_noAF
Pathogenic
0.46
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.16
T;T;.;T
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.73
.;T;T;T
M_CAP
Pathogenic
0.74
D
MetaRNN
Benign
0.084
T;T;T;T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.4
M;M;.;.
MutationTaster
Benign
1.0
D
PrimateAI
Uncertain
0.67
T
PROVEAN
Uncertain
-4.2
D;.;.;D
REVEL
Pathogenic
0.95
Sift
Uncertain
0.020
D;.;.;D
Sift4G
Uncertain
0.029
D;.;.;.
Polyphen
1.0
D;D;.;.
Vest4
0.63
MutPred
0.87
Gain of loop (P = 0.1069);Gain of loop (P = 0.1069);Gain of loop (P = 0.1069);Gain of loop (P = 0.1069);
MVP
0.99
MPC
0.26
ClinPred
0.33
T
GERP RS
4.2
Varity_R
0.89
gMVP
0.95

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.97
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1135071; hg19: chr11-5248029; API